Key Developments: InfuSystem Holdings Inc (INFU.A)

INFU.A on American Stock Exchange

3.18USD
19 Dec 2014
Price Change (% chg)

$0.40 (+14.39%)
Prev Close
$2.78
Open
$2.80
Day's High
$3.18
Day's Low
$2.74
Volume
54,322
Avg. Vol
27,240
52-wk High
$4.50
52-wk Low
$2.08

Search Stocks

Latest Key Developments (Source: Significant Developments)

InfuSystem Holdings Inc reaffirms FY 2014 revenue outlook; comments on FY 2015 revenue outlook
Monday, 10 Nov 2014 06:00am EST 

InfuSystem Holdings Inc:Maintained FY 2014 guidance of high single digit revenue growth and said it expects this rate to continue through FY 2015.  Full Article

Infusystem Holdings Inc reaffirms FY 2014 revenue outlook
Friday, 1 Aug 2014 06:00am EDT 

Infusystem Holdings Inc:Maintains FY 2014 guidance of high single digit revenue growth.  Full Article

InfuSystem Holdings Inc reaffirms FY 2014 revenue outlook
Monday, 5 May 2014 07:00am EDT 

InfuSystem Holdings Inc:Maintains FY 2014 guidance of high single digit revenue growth.  Full Article

Infusystem Holdings Inc reaffirms FY 2014 revenue guidance
Tuesday, 11 Mar 2014 07:00am EDT 

Infusystem Holdings Inc:Reaffirms FY 2014 guidance of high single digit revenue growth.  Full Article

Infusystem Holdings Inc Reaffirms FY 2014 Revenue Guidance
Tuesday, 12 Nov 2013 07:00am EST 

Infusystem Holdings Inc reaffirmed its fiscal 2014 revenue guidance and expects high single digit revenue growth.  Full Article

Faruqi & Faruqi, LLP Launches Investigation Against Infusystem Holdings Inc
Tuesday, 30 Jul 2013 07:50pm EDT 

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a national securities firm headquartered in New York City, is investigating the Board of Directors of InfuSystem Holdings, Inc. for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders' approval for an amendment of the Company's 2007 Stock Incentive Plan.  Full Article

Infusystem Holdings Inc Names Eric Steen Chief Executive Officer
Thursday, 14 Mar 2013 03:05pm EDT 

Infusystem Holdings Inc announced that its Board of Directors has appointed Eric Steen, who has more than 30 years of medical device and pharmaceutical industry experience, as Chief Executive Officer (CEO), effective April 1, 2013. Dilip Singh, who has served as the Company's Interim CEO since April 2012, will step down from that position on the same date, while continuing as a member of the Board.  Full Article

Search Stocks